Figure 1
From: Development of a novel anti-hepatitis B virus agent via Sp1
The anti-viral effect of alpha-glucosidase inhibitor candidates. The vertical and horizontal axis shows the amount of HBV-DNA (copies/mL) and days after infection, respectively. The standard deviation is also shown. Each experiment was repeated three times.
